Invesaro

Stocks BTCS Financial statements

Financial statements

BTCS Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BTCS Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue0.3601.211.691.344.0716.5
Cost of revenue0.2600.270.430.363.1314.5
Gross profit0.0900.941.270.980.952.01
Research and development0.050.710.610.690.760.68
Selling and marketing0.010.010.180.080.010.08
General and administrative1.311.560.991.420.421.591.921.451.031.56
Operating expenses1.551.570.991.431.9918.918.85.32.1931.9
Operating income-1.46-1.57-0.99
Interest expense0.010.090.41.45
Other non-operating income-42.8-43.90.16-0.21-0.571.861.612.1-0.03-3.46
Income tax000000
Net income-44.3-45.5-0.83-1.64-2.56-16-15.97.82-1.27-33.4
EBITDA-1.27-1.57-0.99
EPS, basic-38.23-2.89-0.55-0.86-0.70-2.53-1.020.55-0.08-1.00
EPS, diluted-38.23-2.89-0.55-0.86-0.70-2.53-1.020.45-0.08-1.00
Shares, basic (weighted)1.1615.81.582.033.658.3615.614.116.333.2
Shares, diluted (weighted)1.1615.81.582.033.658.3615.617.516.333.2

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents0.10.30.050.140.521.42.151.461.981.53
Short-term investments0.1
Other current assets00.220.010.020.030.320.120.060.060.15
Total current assets0.10.590.060.421.555.474.12738.1214
Property, plant and equipment00000.010.010.010.010.01
Total assets0.10.590.060.421.5514.19.9227.138.2215
Accounts payable0.770.080.010.030.030.050.080.060.070.04
Accrued liabilities1.920.370.773.98
Short-term debt0.050.2
Total current liabilities45.30.080.320.610.5120.590.984.2563.4
Total liabilities45.30.080.320.610.512-4.40.984.2575.2
Paid-in capital23.8115115117121148161162171311
Retained earnings-69.1-115-115-117-120-136-151-139-140-173
Treasury stock-0
Shareholders' equity-45.30.51-0.26-0.181.0412.114.326.234139
Total equity-45.30.51-0.26-0.181.0412.114.326.234139
Total liabilities and equity0.10.590.060.421.5514.19.9227.138.2215
Shares outstanding2.0646.41.62.545.1312.91615.318.746.9

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-44.3-45.5-0.83-1.64-2.56-16-15.97.82-1.27-33.4
Depreciation and amortization0.180000000.010.010
Stock-based compensation15.52.631.342.420.66
Change in payables0.14-0.670.040.010.040.11-0.06-0.020.02-0.03
Cash from operations-0.83-1.49-0.51-1.5-2.97-4.86-0.78-3.56-3.53-9.78
Capital expenditures-0.01-0-0-0.01-0.01-0.01-0-0.01
Purchases of investments-0.1-0.5
Cash from investing0.390-0-0.37-9.47-8.970.19-2.63-197
Debt issued123
Debt repaid-61.4
Stock issued1.161.853.0111.12.696.68135
Share buybacks-4
Dividends paid0-0.630-2.68
Cash from financing0.411.70.261.593.3515.210.52.696.68207
Net change in cash-0.030.21-0.250.090.380.880.75-0.690.52-0.45
Free cash flow-0.84-1.49-0.51-4.87-0.78-3.57-3.53-9.8
Interest paid1.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.53 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin26.9%Gross profit / revenue.
Net margin-746.3%Net income / revenue.
Operating cash flow margin-47.0%Cash from operations / revenue.
Return on equity (ROE)-319.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-139.0%Net income / average total assets.
R&D / revenue2.6%Research and development expense / revenue.
Stock-based pay / revenue1.1%Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue0.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y304.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y113.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y112.5%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y16.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y310.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y113.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y166.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y461.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y178.7%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y168.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y104.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y28.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y55.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.06xCurrent assets / current liabilities.
Quick ratio0.01x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.01x(Cash + short-term investments) / current liabilities.
Liabilities / assets56.5%Total liabilities / total assets.
Working capital$45.6MCurrent assets - current liabilities.
Tangible book value$38.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.19xRevenue / average total assets.
Fixed asset turnover1,471xRevenue / average property, plant and equipment.
Days payables3 days365 x average accounts payable / cost of revenue.

Per share

MetricValueHow it is calculated
EPS, diluted-$2.49Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.33Revenue / diluted weighted shares.
Operating cash flow per share-$0.16Cash from operations / diluted weighted shares.
Book value per share$0.78Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.78Tangible book value / shares outstanding.
Cash per share$0.01(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$76.2MShare price x shares outstanding.
Enterprise value$75.9MMarket cap + total debt - cash - short-term investments.
P/S4.58xMarket cap / revenue.
P/B1.96xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.96xMarket cap / tangible book value, when positive.
EV/Sales4.57xEnterprise value / revenue.
Earnings yield-162.9%Net income / market cap (the inverse of P/E).
What was BTCS Inc.'s revenue in fiscal 2025?

BTCS Inc. reported revenue of $16.5M for fiscal 2025, 304.8% higher than the year before.

Was BTCS Inc. profitable in fiscal 2025?

No. It reported a net loss of $33.4M.

How much free cash flow did BTCS Inc. generate in fiscal 2025?

Cash from operations of $9.8M minus capital expenditures of $12.8K left free cash flow of -$9.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BTCS Inc.